This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
protein
product name :
Recombinant Equine IL-1ra/IL-1F3 Protein, CF
catalog :
2466-RA-050/CF
quantity :
50 ug
price :
432 USD
citations: 1
Reference
Dakin S, Smith R, Heineg rd D, nnerfjord P, Khabut A, Dudhia J. Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein). J Biol Chem. 2014;289:4919-27 pubmed publisher
product information
master code :
2466-RA/CF
SKU :
2466-RA-050/CF
product name :
Recombinant Equine IL-1ra/IL-1F3 Protein, CF
unit size :
50 ug
description :
The Recombinant Equine IL-1ra/IL-1F3 Protein, CF from R&D Systems is derived from E. coli. The Recombinant Equine IL-1ra/IL-1F3 Protein, CF has been validated for the following applications: Bioactivity.
target :
IL-1ra/IL-1F3
category :
Proteins and Enzymes
buffer :
Lyophilized from a 0.2 ╡m filtered solution in PBS and DTT.
conjugate :
Unconjugated
purity :
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain
species :
Equine
theoretical molecular weight :
17.5 kDa
details of functionality :
Measured by its ability to inhibit IL-1 alpha -dependent proliferation in D10.G4.1 mouse helper T cells. Symons, J.A. etáal . (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. etáal . (eds): IRL Press. 272. The ED50 for this effect is 0.75-3.0 ╡g/mL in the presence of 50 pg/mL of rhIL-1 alpha .
endotoxin note :
<0.01 EU per 1 ╡g of the protein by the LAL method.
accessionNumbers :
O18999.1
applications :
Bioactivity
source long :
E. coli -derived equine IL-1ra/IL-1F3 protein His26-Gln177, with an N-terminal Met
source short :
E. coli
USD :
432 USD
alt names :
DIRA, ICIL-1RA, IL1F3, IL-1F3, IL-1ra, IL1RA, IL-1ra3, IL1RN, IL-1RN, interleukin 1 receptor antagonist, IRAP, MVCD4
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.